| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.001 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |